Patients with mild cerebral infarction should be given selective oral anti-platelet aggregation or anticoagulation drugs, such as aspirin, clopidogrel or warfarin, and oral statins, such as simvastatin, atorvastatin and rasulvastatin, to lower lipids and stabilize plaque and prevent reinfarction, depending on the cause. Oral medications to improve brain metabolism, such as olacitentan, piracetam, cytarabine, cerebral protein hydrolysate, etc. Administering drugs to activate blood circulation and resolve blood stasis, which are commonly used clinically, such as panax ginseng, salvia, safflower, dilaudid and ginkgo biloba preparations. Patients with mild cerebral infarction have mild clinical signs and symptoms, and generally the signs and symptoms of focal neurological deficits are predominant, such as hemiparesis, monoparesis, hemianesthesia or speech dysfunction, generally without consciousness impairment, and usually have a better prognosis.